专利检索 ap:"Shitij Kapur" 第 1 页

1.

发明申请
Atypical antipsychotic agents having low affinity for the D2 receptor 审中-公开

公开(公告)号：US20060166965A1

公开(公告)日：2006-07-27

申请号：US11325600

申请日：2006-01-05

申请人： Shitij Kapur , Robert McClelland

发明人： Shitij Kapur , Robert McClelland

IPC分类号： A61K31/554 , A61K31/553 , C07D417/04

CPC分类号： C07D267/20 , C07D281/16

摘要： The present invention provides novel compounds of Formula I: The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia).

2.

发明申请
Atypical antipsychotic agents having low affinity for the D2 receptor 审中-公开
标题翻译：对D2受体具有低亲和力的非典型抗精神病药

公开(公告)号：US20050222121A1

公开(公告)日：2005-10-06

申请号：US11031352

申请日：2005-01-10

申请人： Shitij Kapur , Robert McClelland

发明人： Shitij Kapur , Robert McClelland

IPC分类号： A61K31/553 , A61P25/18 , C07D267/20 , C07D281/16 , A61K31/554 , C07D413/02 , C07D417/02

CPC分类号： C07D267/20 , C07D281/16

摘要： The present invention provides novel compounds of Formula I: The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia).

摘要翻译： 本发明提供式I的新化合物：本发明还涉及包含式I化合物的药物组合物和使用式I化合物治疗神经精神障碍（例如精神病，抑郁症，精神分裂症）的方法。

3.

发明申请
Atypical antipsychotic agents having low affinity for the D2 receptor 审中-公开
标题翻译：对D2受体具有低亲和力的非典型抗精神病药

公开(公告)号：US20090149442A1

公开(公告)日：2009-06-11

申请号：US11657621

申请日：2007-01-25

申请人： Shitij Kapur , Robert McClelland

发明人： Shitij Kapur , Robert McClelland

IPC分类号： A61K31/554 , C07D281/16 , C07D267/20 , A61K31/553 , A61P25/18

CPC分类号： C07D267/20 , C07D281/16

摘要： The present invention provides novel compounds of Formula I: The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia).

摘要翻译： 本发明提供式I的新化合物：本发明还涉及包含式I化合物的药物组合物和使用式I化合物治疗神经精神障碍（例如精神病，抑郁症，精神分裂症）的方法。

4.

发明授权
Atypical antipsychotic agents having low affinity for the D2 receptor 失效

公开(公告)号：US06890919B2

公开(公告)日：2005-05-10

申请号：US10178618

申请日：2002-06-25

申请人： Shitij Kapur , Robert McClelland

发明人： Shitij Kapur , Robert McClelland

IPC分类号： A61K31/553 , A61P25/18 , C07D267/20 , C07D281/16 , C07D413/04 , A61K31/496 , C07D417/04

CPC分类号： C07D267/20 , C07D281/16

摘要： The present invention provides novel compounds of Formula I: The invention further relates to pharmaceutical compositions comprising compounds of Formula I and to methods of using compounds of Formula I to treat neuropsychiatric disorders (e.g., psychosis, depression, schizophrenia).